Recombivax

Known as: Recombivax HB, Recombivax HBR, Recombivax-HB 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1991-2015
02419912015

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
BACKGROUND The hepatitis B surface antigen (HBsAg) has been administered over the last 20 years as a parenteral vaccine against… (More)
Is this relevant?
2010
2010
BACKGROUND Multiple studies have shown excellent response rates after hepatitis B immunization in youth; however, one previous… (More)
Is this relevant?
2008
2008
BACKGROUND Long-term follow-up studies of populations that received recombinant hepatitis B (HB) vaccination beginning at birth… (More)
Is this relevant?
2007
2007
BACKGROUND Apical Membrane Antigen 1 (AMA1) of Plasmodium falciparum merozoites is a leading blood-stage malaria vaccine… (More)
  • figure 1
  • figure 2
  • table 1
  • table 2
  • table 3
Is this relevant?
2005
2005
BACKGROUND Few data are available concerning the long term immunogenicity of the pediatric doses of hepatitis B vaccines given to… (More)
Is this relevant?
Review
2004
Review
2004
Hepatitis B disease has caused a heavy burden worldwide. The development of an immunogenic, efficacious and safe vaccine to… (More)
Is this relevant?
2002
2002
BACKGROUND Diminished antibody responses to the dosage of hepatitis B (HB) vaccine indicated for healthy adults has led to a… (More)
Is this relevant?
2001
2001
OBJECTIVES Hoping to increase hepatitis B (HB) vaccination of adolescents, we did the following: 1) studied if modified regimens… (More)
Is this relevant?
1995
1995
A randomized trial compared the safety and immunogenicity of Engerix-B (EB) 20 micrograms administered intramuscularly (IM) at 0… (More)
Is this relevant?
1993
1993
PURPOSE Currently available hepatitis B vaccines are recombinant, yeast-derived preparations given in 10-micrograms or 20… (More)
Is this relevant?